Abstract
A total of 51 patients with chronic stable plaque psoriasis extensive enough to warrant hospital admission were entered in a double-blind placebo-controlled trial. They were treated with conventional tar and dithranol, and at the same time randomly allocated to receive either 12 × 500 mg capsules of combined fish oil and evening primrose oil (Efamol Marine) or 12 capsules of placebo (liquid paraffin) daily to ascertain whether their remission period could be prolonged. They were assessed 1, 4 and 7 months after discharge. Of the 51 patients, 37 completed 4 months and 23 completed 7 months. All patients improved substantially during hospitalization, and this improvement continued until 1 month after discharge, but then diminished. No significant difference was noted in the rate of deterioration between those patients on Efamol Marine and those on placebo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.